Dubiotech, part of Dubai Holding, plans to issue tenders for two of the development's building packages later this year. Documents will be issued in July for a laboratory complex with a built-up area of 32,500 square metres and an 18-storey twin-tower headquarters building with a built-up area of 57,000 square metres. Parsons International of the US is the infrastructure consultant. A US joint venture (JV) of Parsons and CUH2A is the design consultant for the laboratory, and a US/German JV of CUH2A and Kling Consult is the consultant for the headquarters (MEED 10:2:06).

Dubiotech aims to become a biotechnology hub. It will promote research with biotech firms and international academic institutions, and attract drugs companies with its intellectual property legislation.